Danaher Corporation (DHR)
Medical - Diagnostics & Research · Healthcare · $128.3B
Intrinsic Value (Consensus)
$84.03
Current Price
$181.35
Margin of Safety
-53.7%
53.7% Above Intrinsic Value
Value: $84
Price: $181
Valuation Model Estimates
Current Price: $181.35
DCF (Discounted Cash Flow)
$94.24
Graham Number
$91.84
Earnings Power Value
$49.03
Relative Value (P/E)
$101.00
Dividend Discount Model
Not applicable
—
Consensus Value
$84.03
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
49
Profitability
15/25
Strength
23/25
Valuation
4/25
Growth
7/25
Key Financials
- EPS (TTM)
- $5.05
- EPS (Forward)
- $5.15
- Book Value
- $74.23
- P/E Ratio
- 36.0
- Forward P/E
- 35.3
- PEG Ratio
- —
- ROE
- 6.9%
- Debt/Equity
- 35%
- Revenue Growth
- 2.9%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 0.83
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance